Advances in RAS Therapeutics for Pancreatic Cancer
New England Journal of Medicine · 07.05.2026 · 394 (18) · 1857-1861
DOI: 10.1056/nejme2600517 ↗Kurz gefasst
Editorial in der Zeitschrift New England Journal of Medicine, erschienen am 07.05.2026. Verfasst von Channing J Der und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill.
- Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill.
ORCID-Profile: Jen Jen Yeh
Zitieren
APA
Der, C. J., & Yeh, J. J. (2026). Advances in RAS Therapeutics for Pancreatic Cancer. New England Journal of Medicine, 394(18), 1857-1861. https://doi.org/10.1056/nejme2600517
Vancouver
Der CJ, Yeh JJ. Advances in RAS Therapeutics for Pancreatic Cancer. New England Journal of Medicine. 2026;394(18):1857-1861. doi:10.1056/nejme2600517
BibTeX
@article{Der2026,
author = {Der, Channing J and Yeh, Jen Jen},
title = {Advances in RAS Therapeutics for Pancreatic Cancer},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {18},
pages = {1857--1861},
doi = {10.1056/nejme2600517}
}
EUVIMED